Failed neonatal hearing screening [% (n failed hearing screening/n with risk factor) | OR | 95% CI | p | |
---|---|---|---|---|
All | 11% (788/7056) | Ref. | ||
Birth weight# | 0.91 | 0.88-0.94 | 7.3 × 10-10* | |
No Aminoglycosides, m.1555A>G - | 8.5% (224/2636) | 1.26 | 1.07-1.49 | 0.0058* |
No Aminoglycosides m.1555A>G + | 0% (0/2) | |||
Aminoglycosides m.1555A>G - | 12.7% (561/4408) | |||
Aminoglycosides m.1555A>G + | 30% (3/10) | |||
Vancomycin treatment | 15.8% (349/2208) | 1.24 | 1.04-1.47 | 0.015 |
Furosemide treatment | 17.6% (238/1355) | 1.29 | 1.08-1.57 | 0.0066* |
Cytomegalovirus-infection | 27% (6/22) | 1.80 | 0.69-4.7 | 0.23 |
Infants with BPD | 18.6% (195/1048) | 1.21 | 0.99-1.49 | 0.067 |